-
news · 24 Jun 2026
x-tosis lands a $2.74M Michael J. Fox Foundation grant to push XTS001, a brain-penetrant VDAC1-oligomerization blocker, toward Parkinson's
x-tosis has been awarded a $2.74M grant from The Michael J. Fox Foundation to advance XTS001, an oral, brain-penetrant molecule that blocks VDAC1 oligomerization, toward Parkinson's development.